Previous
Poster Home
Next
Real-world effectiveness of erythropoiesis-stimulating agents after luspatercept in patients with myelodysplastic syndromes: a retrospective analysis of a large healthcare claims database in the United States
07:30am - 03:35pm EDT - April 6, 2024
Information
Resources
Play Recording
Abstract: JNCCN23-0560
https://jnccn.org/view/journal...
Author(s):
Kashyap Patel, MD
, Minnesota Oncology
Derek Tang, PhD, MS, BSPharm
, Health Outcomes Research Leader, Bristol-Myers Squibb
Tags:
Outcomes and Health Services Research
Display Label
Action
High Resolution Poster_Hanna _NCCN 2024_ ESA post-lusp.pdf
Download Handout